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Abstract: Axonal transport plays a crucial role in neuronal morphogenesis, survival and 
function. Despite its importance, however, the molecular mechanisms of axonal transport 
remain mostly unknown because a simple and quantitative assay system for monitoring this 
cellular process has been lacking. In order to better characterize the mechanisms involved 
in axonal transport, we formulate a novel computer-assisted monitoring system of axonal 
transport. Potential uses of this system and implications for future studies will be discussed. 
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1. Introduction  
Neurons are highly polarized cells having axons and dendrites, with proper neuronal differentiation, 
survival and function heavily dependent on the axonal and dendritic transport machinery  [1,2]. In 
axons, the molecules required for synapse formation are synthesized in the cell body and transported to 
the synaptic area. Molecules such as neurotrophins are received in the growth cone or nerve terminal, 
and transported to the cell body. This transport machinery depends on two families of motor proteins 
to  transport  molecules  along  microtubules,  kinesin  and  dynein  [1,3].  Defects  in  axonal  transport 
reportedly  can  lead  to  neurodegenerative  pathology  and  related  disorders,  such  as  Schizophrenia, 
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Alzheimer’s (AD), Parkinson’s, other motor neuron diseases and drug-induced neuropathies [4–6], 
highlighting the importance of understanding the mechanisms of axonal transport.  
For the analysis of axonal transport, conventional assay systems have been utilized, such as isotope 
tracer  techniques,  video-enhanced  differential  interference  contrast  microscopy  or  fluorescence 
recovery  after  photobleaching  (FRAP)  via  the  introduction  of  green  fluorescence  protein  
(GFP)-tagged  proteins  [7].  Current  studies  suggest  that  regulation  of  axonal  transport  occurs  at 
multiple levels, including modulation of the microtubule track, cargo-specific adaptors and scaffolding 
proteins that coordinate cargo-bound motors [8]. Oddly enough, little is known about the regulatory 
mechanisms of axonal transport. This may partly be because earlier methods are time-consuming and 
depend on a subjective element. Indeed, up to now, little attention has been paid at ligand-specific 
regulation of axonal transport. We previously reported using a video-enhanced contrast differential 
interference video camera system to establish that a repulsive axon guidance molecule, Semaphorin3A 
(Sema3A), induces anterograde and retrograde axonal transport [9–11]. It is only recently that we 
found that Sema3A plays an important role in neuronal morphogenesis, and functions by regulating 
axonal transport [12]. Therefore, the development of a simple and objective assay system to evaluate 
axonal transport has long been awaited. We have recently developed a computer-assisted monitoring 
system for axonal transport [4]. In this review, we will just briefly summarize the physiology and 
pathophysiology of axonal  transport,  and discuss  about  the validity and general  versatility of  this 
method, and our tasks for the future. 
2. Physiological Functions of Axonal Transport 
2.1. The Role of Axonal Transport in Neural Survival 
In  the  peripheral  and  central  neurons,  neurotrophins  are  important  regulators  for  the  survival, 
differentiation and maintenance of nerve cells. Recent studies indicate that axonal transport plays an 
important role in neuronal survival [13,14]. In fact, prosurvival signals are blocked by the inhibition  
of retrograde axonal  transport  [15]. Nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF),  neurotrophin-3  and  neurotrophin  4/5  are  members  of  the  neurotrophin  family.  Each 
neurotrophin binds with high affinity to a specific Trk receptor tyrosine kinase. These growth factors can 
also induce cell death through the p75 neurotrophin receptor, a member of the tumor necrosis factor 
receptor  superfamily  [16].  Upon  ligand  binding,  Trk  receptors  undergo  dimerization  and 
autophosphorylation on several key tyrosine residues, which then serve as docking sites for a variety of 
effector  proteins.  NGF,  which  is  produced  and  released  by  target  cells  innervated  by  peripheral 
neurons,  acts  on  TrkA  receptors  located  on  the  axon  terminals  of  innervating  neurons,  initiates 
biochemical signals locally within distal axons and sends signals retrogradely to neuronal cell bodies 
and ultimately to  their nuclei. Recent  findings  provide strong support for a “Signaling Endosome 
Model” in which NGF-TrkA complexes undergo internalization in distal axons and are then physically 
translocated along the axonal microtubule network to cell bodies where they can initiate or propagate 
prosurvival  signals  [17].  However,  the  identity  of  the  endocytotic  vesicular  carrier(s)  and  the 
mechanisms involved in retrogradely transporting the signaling complexes remain unknown [18].  
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2.2. The Role of Axonal Transport in Neural Network Formation 
During development, after postmitotic division, neurons extend their neurites, and recognize their 
environments to make synapses with their appropriate target cells. Although a role of local protein 
synthesis  in  growth  cone  has  now  been  appreciated  in  this  process,  all  the  proteins  required  
in the axon, growth cone and synaptic terminal must be transported down the axon after they are 
synthesized in the cell body. In neurons, various kinds of receptors for axon guidance molecules must 
be  localized  properly  to  axons  or  dendrites  for  appropriate  neuronal  wiring.  Signaling  outcomes 
downstream of ligand binding are determined by the location, levels and residence times of receptors 
on the neuronal plasma membrane. Therefore, the mechanisms controlling the trafficking of these 
receptors  are  crucial  to  the  proper  wiring  of  circuits.  Indeed,  the  molecular  machinery  involving 
membrane trafficking has been implicated in axon guidance.  
For example, UNC-51 is a serine/threonine kinase homologous to yeast Atg1, required for autophagy, 
a  form  of  catabolic  vesicle  trafficking.  In  the  unc-51  Caenorbabditis  elegans  mutants,  some  axon 
guidance defects have been observed [19]. In addition, in unc-51 worms, an aberrant localization of 
netrin/UNC-5 and its receptor UNC-6 [20,21], are associated with axon guidance defects. Given that 
UNC-6  is  required  for  dorso-ventral  axon  guidance,  altered  localization  of  UNC-6  in  this  mutant 
probably  causes  or  reflects  UNC-6  secretion  defects,  which  should  result  in  dorso-ventral  axon 
guidance  defects  [20,21].  In  support  of  this  hypothesis,  unc-51  mutant  shows  defective  dorsally 
directed axon pathfinding by DD/VD neurons [20]. Such defects in axon guidance or neurite extension 
might  also  be  caused  by  impaired  membrane  supply  at  the  growth  cone  via  non-selective  axonal 
transport.  Surprisingly  however,  our  findings  suggest  that  UNC-51  regulates  the  localization  of 
synaptobrevin and UNC-5, at least in regard to its accumulation in the cell body, but does not appear to 
regulate  the  localization  of  proteins  generally  in  neurons  [20].  More  direct  evidence  for  this  link 
between axon guidance processes and axonal transport is seen in the mutant worm Kif1A/unc-104 [22]. 
In unc-104, the neurons show an abnormal accumulation of Venus::UNC6 in the cell body, and this 
mutant shows defects in the guidance of dorso-ventral axons, suggesting that the abnormal localization 
of UNC-6 disturbs the positional information it provides (Asakura et al.: unpublished observation). 
These findings suggest that axonal transport plays an important role in axon guidance mechanisms  
by regulating the localization of axon guidance molecules or their receptors. Another example that 
shows close relationship between axonal transport and axon guidance is KIF2A [2]. KIF2A is expressed 
predominantly in the developing brain, especially in neuronal growth cones.  In the brains of  Kif2A 
knockout mice, axon bundles labeled with DiI crystals show an increased number of horizontally running 
neurites in mutant mice, whereas axons run longitudinally in wild-type mice. In vitro experimentation 
shows  that  KIF2A  depolymerizes  microtubules  in  a  ATP-dependent  manner.  Consistently,  in  the 
absence of KIF2A, microtubules continue to elongate even after reaching the cell periphery, while in 
wild-type cells, elongating microtubules began to depolymerize when reaching cell periphery. These 
observations raise the question of how axonal transport is regulated so that these guidance molecules 
are presented to growth cones for proper axonal navigation or wiring.  Int. J. Mol. Sci. 2012, 13                      
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2.3. Axonal Transport and Neural Plasticity 
Neurotrophic factors such as NGF and BDNF play important roles, not only in neuronal development 
and survival, but also in neural plasticity. Recently, presynaptic BDNF promotes postsynaptic long-term 
potentiation (LTP) in the dorsal striatum [23]. On the other hand, as described above, neurotrophic 
factors activate active downstream effectors such as Trk receptors at presynaptic sites and are transported 
to the same via a retrograde signaling endosome [8]. Therefore, it is conceivable that neurotrophins 
regulate  neural  plasticity  through  both  postsynaptic  and  presynaptic  mechanisms.  However,  the 
question remains open as to whether retrograde signaling elicited by neurotrophic factors are involved 
in neural plasticity. 
2.4. Pathophysiology of Axonal Transport 
Evidence implicating axonal transport defects in the pathogenesis of neurodegeneration has come 
from the identification of mutations in the motors that drive axonal transport [8]. For example, the 
identification of mutations in dynein provides evidence that defects in axonal transport are sufficient to 
cause neuronal degeneration. Furthermore, recent studies suggest that slowing of axonal transport is  
an early event in the pathogenesis of a number of neurodegenerative diseases such as amyotrophic 
lateral sclerosis (ALS) [24,25], Huntington’s disease (HD) [26,27] and AD [28]. Although the exact 
mechanisms of impaired axonal transport are unknown, some suggestive evidence has been obtained in 
recent years. In AD, the pathological hallmarks, neurofibrillary tangles, neuropil threads and senile 
plaques, are potentially linked to alterations of the axonal compartment. Familial AD mutations in  
β-amyloid precursor protein (βAPP) and in presenilin genes alter the production of amyloid-β peptides 
(Aβs), the major constituents of senile plaques, suggesting that proteolytic processing of βAPP into 
Aβs plays a central role in AD pathogenesis. Impairing axonal transport by reducing the dosage of a 
kinesin molecular motor protein enhances the frequency of axonal defects and increased Aβs levels 
and  amyloid  deposition  [28].  HD  is  one  of  nine  neurodegenerative  diseases  that  result  from  the 
expansion of CAG repeats, leading to proteins containing abnormally long polyQ tracts. It has been 
proposed that misfolding of the mutant protein triggers a cascade of events, ultimately causing disease. 
Huntingtin  is  a  cytoplasmic  protein  with  unknown  function.  In  HD  brain,  aggregates  of  mutant 
huntingtin are observed in nuclear inclusions and in dystrophic neurites. Expression of human huntingtin 
exon 1 with expanded polyQ causes axonal transport defects in larval neurons of Drosophila, perhaps by 
blocking axonal processes by polyQ accumulations, neuronal cell death and neurodegeneration  [27]. 
However,  the  mechanisms  and  pathophysiological  significance  of  axonal  transport  are  unknown  
at present. 
2.5. Comparison of the Analytical Methods for Axonal Transport 
A growing body of evidence for the importance of axonal transport has therefore prompted us to 
establish a computer-assisted software system to monitor axonal transport. Recently, similar attempts 
have been reported independently to detect and track vesicles along neuronal axons [4,29,30]. The 
time-sequence images of moving vesicles, which are observed by fluorescence microscopy with probes, 
such as fluorescence recovery after FRAP, GFP, and CM-DiI, are used for analyzing axonal transport Int. J. Mol. Sci. 2012, 13                      
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as inputs. The methods are classified into two approaches: the particle tracking in time-sequence image 
frames  [4,29,30] and analysis using  a kymograph image  [29–31]. We will briefly introduce these 
methods in this section. 
2.6. Difficulties in Axonal Transport Analysis 
Figure 1 shows frames of a CM-DiI-labeled time sequence image. As shown in this figure, the 
following difficulties appear in the detection, tracking and analysis of fluorescence microscopic axonal 
transport images. 
(1).  The gray scale of the vesicle is not similar and the images have a lot of random noise, which 
made vesicle detection difficult using simple image processing technologies. 
(2).  The vesicles move bi-directionally along the axon with different velocities and/or opposite 
directions. 
(3).  Since the vesicles move in close proximity in a narrow passageway, the vesicles may appear as 
a single particle on an image frame and then as several particles on the next. 
Figure 1. Axonal transport visualized with CM-DiI staining in the axon of chick dorsal 
root ganglion (DRG) neuron. Dissociated DRG neurons were plated and 12–14 h thereafter 
CM-DiI was solubilized and added to the cultured neurons. To visualize moving particles, 
CM-DiI  destaining  was  performed  by  further  incubating  the  DRG  neurons  for  6  h  in  
the  absence  of  CM-DiI.  The  particles  indicated  by  the  arrows  and  arrowheads  exhibit 
representative  continuous  anterograde  and  retrograde  movement,  respectively.  
From [Goshima et al. 2010] [4].  
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These difficulties have to be solved when developing methods of axonal transport analysis using 
fluorescence microscopy. As discussed in the following section, in order to differentiate between those 
vesicles with different velocities and directions in a narrow passageway, strategies have been explored, 
such as use of Bayesian estimation [30], particle movement diagram [4] and kymograph image [29,31]. 
2.7. Computer-Based Particle Detection and Tracking Methods 
The  approach  using  the  particle  tracking  in  time-sequence  image  frames  generally  consists  of 
particle detection, tracking and analyzing processes. In the detection process, particles on each frame 
in the input time-sequence image are firstly detected. In the tracking process, a pattern of each particle 
detected in an image frame is searched on those in the next frame to make a correspondence between 
the patterns in successive frames. Then, the traffic paths of particles are also found through the whole 
image sequences in this process. After finding the traffic paths, quantitative analysis is made, such as 
the velocity distributions of the antero- and retrograde movement along an axon. 
In  order to overcome the above-mentioned difficulties on vision-based axonal transport analysis, 
Broeke et al. propose a method for tracking particles which are detected using a heuristic approach on 
subsequence image frames [30]. In their method, they introduced an appearance model which describes 
the pixel intensities of a particle as a discrete histogram and a multi-hypothesis tracking which enables 
the finding of paths, even when particles are observed to merge into one, and, conversely, when one 
particle appears to split into many. They have also proposed a method using a recursive Bayesian 
estimation algorithm and auction algorithm to reduce computation time while preserving the accuracy 
of detection and tracking. 
To  overcome  the  difficulties  mentioned  above,  we  have  taken  a  different  approach.  First,  we 
employed  chloromethylbenzamide  dialkylcarbocyanine  (CM-DiI)  [4]  as  a  probe  to  visualize 
membranous organelles being transported along the axon in chick dorsal root ganglion (DRG) neurons. 
We have tried various kind of fluorescence dyes, GFP-tagged proteins etc. to visualize axonal transport. 
Among them, we found CM-DiI staining produces the highest signal-to-noise ratio and resolution in 
live imaging of moving vesicles along the axons. We recorded the moving CM-DiI labeled particles 
with a laser-scanning microscope, analyzed the axonal transport rate and examined the effects of several 
pharmaceutical agents on axonal transport. We studied the subcellular distribution of CM-DiI. The signal 
of CM-DiI was associated with EGFP-tagged lysosomal-associated membrane protein introduced into 
DRG neurons, suggesting that the majority of the moving particles labeled with CM-DiI are composed of 
endosomal and lysosomal vesicles in DRG neurons. In our method, the differential interference and 
fluorescence  microscopic  sequential  images  are  used  as  inputs.  Our  method  also  consists  of  two 
processes of analysis, particle detection and particle tracking (Figure 2A). The software consists of two 
phases, the detection of a particle and then the tracking of a particle. The software details of this 
system are described below. In the particle detection process, the axonal region is first detected on an 
image using a differential interference microscopic image (Figure 2C). Subsequently, noise reduction 
and particle shape enhancement are carried out using median filtering and convolution filtering on the 
fluorescence microscopic images. The resulting image revealed CM-DiI–labeled vesicles in the axonal 
regions. Since the vesicles have a wide range of intensities, general binarizing technologies do not 
always  detect  them  stably.  In  order  to  solve  this  problem  of  vesicles  having  a  wide  intensity Int. J. Mol. Sci. 2012, 13                      
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distribution and background having random noises, particles are detected by a method of estimating 
the shape of particles using separability filtering [32]. Two designated regions, the central region Rc 
and the surrounding region Rs around a particle, are considered in this method, then the ratio of the 
variances 
2 2 / i b H     of the inter-region to the intra-region is evaluated. In our particle detection, 
using the filters with different radius, the size of the filter with maximum output is considered as that of 
the vesicle. The use of separability filter bank with different sizes enables us to detect both position and 
radius size of a particle shown in Figure 2B, even for particles of weak intensity with background noise. 
Figure  2.  An  image-processing  algorithm  of  axonal  transport  analysis.  The  proposed 
algorithm  for  axonal  transport  analysis  consists  of  two  phases,  particle  detection  and 
particle tracking (A). In panel (B), a solid line shows the cross section of an image. Where 
size of the region fits a vesicle, as in position (a), both of the variances, 
2
c   and 
2
s  , in both 
center and surround regions become low, and the difference between the mean intensities 
c P  and  s P , high. On the other hand, where the size does not fit a vesicle, as in position (b), 
either variance, 
2
c   or 
2
s  , becomes high, and the difference, low. Consequently, the ratios 
a H  and  b H  of variables of inter- to intra-regions have a high value at position (a) and a low 
value  at  (b).  The  detected  particles  are  tracked  by  global  evaluation  using  a  particle 
movement diagram model after the determination of successive image frame correspondence. 
Examples of the results of particle detection (C) and of the particle movement diagram (D) 
are shown. In panel (C), an input of the differential interference image (a), an image after 
detection of the axonal region detection (b), and a result of the particle detection on a 
fluorescence microscopic image frame (c) are shown. A magnified image of the boxed area 
in image c is shown in image d. In panel (D), the lines represent the time course of the 
movement of each particle in the diagram, which is similar in appearance to a train schedule 
diagram.  The  circles  in  the  figure  show  the  crossing  points  in  the  diagram,  where  the 
particles encounter or get in front of each other; (E) Parameters of a global reconstruction 
evaluation. Li, Ii, H, and Di are the time durations of the stable route element i, the time 
interval, the angle, and the distance between the elements i and i + 1, respectively. From 
[Goshima et al. 2010] [4]. 
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Figure 2. Cont. 
 
In our method, particle tracking is composed of local and global tracking processes. The local 
tracking  process  is  try  to  find  the  correspondence  between  the  patterns  of  the  same  vesicle  in 
successive image frames based on the weighted average of differences in the average intensity, the 
motion vector and the detected particle size on the successive frames. To reduce the tracking errors 
that may occur using only local tracking, we use a train schedule-like diagram, as shown in Figure 2D. 
In the diagram, lines represent the time courses of moving particles. We call it a particle movement 
diagram. Using the particle movement diagram, it was easy to determine whether a particle tracking 
route was stable or not: At the crossing points in the diagram, particles encounter or get in front of 
each other, which may increase the possibility of errors on the results of local tracking. On the other 
hand, where each particle moved alone on a line between crossing points, the likelihood of error would 
be low. In the global tracking, the tracking routes are first divided into stable route elements at the 
crossing points. Then, each combination of the stable route elements is evaluated to find the set of 
optimum  tracking  routes,  so  as  to  minimize  the  following  evaluation  function  using  a  
genetic algorithm [33]. 
        i l i i i d i h a L C I C D C H C E  
where,  i H ,  i D , and  i I  are the difference between the tail and head angles, the distance and the frames 
between the stable route element i and the successive route element i + 1 in a given evaluation route; 
i L  is the number of frames of the element i, as shown in Figure 2E. By minimizing  a E , the elements 
smoothly connected without gaps and with long paths are found for members in an evaluation route. Int. J. Mol. Sci. 2012, 13                      
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Welzel et al. proposes a method using Hough transform [31], in order to detect line elements in the 
image map stably under the difficulties that appeared on the fluorescence microscopic axonal transport 
images. The Hough transform is a well-known algorithm to extract lines, which has been applied to 
various fields of image analysis [34], such as automated industrial inspection, computer vision and 
recognition systems. Their method first detects the axonal region and generates the kymograph from 
the input time sequence image frames. The binary image is obtained from an edge image after a Canny 
edge detector is applied to the kymograph. Then, the edge points in a binary kymograph image are 
voted on a parameter accumulation space. Since the accumulations in the parameter space correspond 
to lines in the kymograph image, even weak lines can be detected stably on the parameter space by 
finding the local maxima.  
Mukherjee et al. proposed another method using kymograph [29]. After generating a kymograph 
image, they proposed a particular filtering method to sharpening lines on the kymograph, which is 
based on a voting algorithm defined by orientation distribution function. Then, the lines are detected 
using an algorithm of minimum set covering, so as to minimize the total cost of curve coverage per 
unit area on the kymograph image, in order to avoid the above-discussed difficulties of fluorescence 
microscopic axonal transport images (Figure 3). 
Figure 3. Frames from a video (18 μm × 18 μm region at 1.8 fps) along mouse cortical 
neurons  showing  transport  of  BDNF  granules.  A  space–time  map  (kymograph)  of  the 
video showing the same granule motion. From [Mukherjee et al. 2011] [29]. 
 
Time (s) 
2.8. Velocity Distribution of Particle Movements 
The goal of computer-based methods is generally to obtain the “velocity distribution of particles” of 
axonal transport from the particle paths obtained from the tracking process, by evaluating the number 
and instantaneous velocity of particles moving along the axons. However, we found different kinds of 
“velocity distribution of particles” were reported in previous papers: one is a velocity distribution of all 
particles in the axonal region, and another is a velocity distribution of passing particles, which are 
counted at a determined point in an axon. The velocity distribution of passing particles is suitable for Int. J. Mol. Sci. 2012, 13                      
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representing materials flow, since the distribution tends to become high in proportional to the particle 
velocity. For example, this distribution of static particles would always be zero. On the other hand, 
distribution does not depend on their velocity. So, when we need to compare the results from the 
different distribution, some compensation is needed before comparison.  
In our previous report, we estimated and compared the number of CM-DiI-labeled vesicles moving 
across successive lines drawn every 1 μm from the cell body and perpendicularly to the long axis of 
the axon (Figure 4A) [4]. We found that the number of anterograde and retrograde vesicles varied 
among the monitoring points along the axons, consistent observation that the movement of organelles 
in  axonal  transport  is  salutatory,  and  individual  organelles  start  and  stop  repeatedly.  To  monitor 
movement dynamics of axonal transport, we therefore sought to determine the instantaneous velocity 
of CM-DiI-labeled vesicles along axons. Furthermore, to minimize data fluctuation, we estimated the 
summation of the data obtained from a total of more than 70 virtual lines drawn at intervals of 1 μm 
along the axon starting from the origin of the axon. The histogram of anterograde and retrograde 
axonal transport monitored with this system revealed a bimodal distribution pattern in anterograde 
axonal transport, with two peaks being observed at the velocity of 0.96 and 2.88 μm/s (Figure 4C). The 
histogram of retrograde axonal transport revealed a unimodal pattern, with one peak at the velocity of 
0.72 μm/s (Figure 4D). These distribution patterns are consistent with previous observations on the 
instantaneous  velocity  of  anterograde  and  retrograde  axonal  transport  [10,35].  On  the  other  hand, 
Broeke et al. proposed a model and a recursive Bayesian estimation algorithm that exploit intrinsic 
information contained in an image sequence obtained from cultured cortical neurons overexpressing 
Sema3A-EGFP [30]. An EGFP-tagged version targets large dense core vesicles, similar to endogenous 
Sema3A, and Sema3A labeled vesicles, showing bi-directional movement along axons. The algorithm 
is sequential and uses information extracted from previous frames to predict the most likely object 
configurations. In this system, they evaluated average vesicle velocity of 0.45 μm/s for anterograde, 
and  of  0.67  μm/s  for  retrograde  transport,  respectively.  Although  the  value  for  retrograde  axonal 
transport  is  comparable  to  those  obtained  with  CM-DiI-labeled  vesicles  in  DRG  neurons  [4],  the 
velocity  histogram  for  anterograde  axonal  transport  does  not  show  bimodal  distribution,  which 
provides contrast to our results of anterograde transport. The average velocity of anterograde axonal 
transport of Sema3A labeled vesicles (0.45 μm/s) appears to correspond to the lower value (0.96 μm/s) 
of instantaneous velocity of DiI-labeled particles. As mentioned above, there are two kinds of the 
velocity distribution of vesicles: the velocity distribution of all particles in the axonal region, and the 
velocity distribution of passing vesicles. Although the exact reasons are unknown, it is possible that 
these two different kinds of velocity distribution may be related to this discrepancy on the velocity 
histogram of anterograde axonal transport [4,30].  Int. J. Mol. Sci. 2012, 13                      
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Figure 4. Analysis of axonal transport of particles visualized with CM-DiI in the axon of 
DRG  neurons.  (A)  Images  of  a  moving  particle  visualized  with  CM-DiI  in  an  axon. 
Arrowheads  indicate continuous  movement  of  CM-DiI-labeled particles  crossing  a line 
drawn every 1 μm on an axon; (B) The summation of the number of antero- and retrograde 
moving particles crossing the 74 virtual lines drawn every 1 μm on the axon was estimated 
for 2-min time periods (one frame). Values are the means ±  S.E.M. of the number of 
moving  particles  in  each  fraction  (n  =  14).  Instantaneous  velocity  histograms  of  
antero-  (C)  and  retrograde  (D)  axonal  transport  are  shown.  Data  are  means  ±   S.E.M.  
(n = 15). The velocity range is 0.24 μm/s. Scale bar, 1 μm. From [Goshima et al. 2010] [4]. 
 
2.9. An Example of Computational Analysis of Axonal Transport: A Neurotoxicity Test 
Various kinds of therapeutic agents have neurological side effects, and some have been associated 
with the impairment of axonal transport [5,27]. However, there have been no reports of systemic drug 
screening based on the effects on axonal transport. We investigated the effects of various pharmacological 
reagents on axonal transport and checked whether our automated analysis system was applicable in this 
regard: this comprised an important proof-of-principle required for the further development of drug 
screening. We first tested the effects of lidocaine on axonal transport in DRG neurons. Lidocaine  
is widely used as a local anesthetic, and has been reported to exert an inhibitory effect on axonal 
                       Velocity (m/s)                                               Velocity (m/s) Int. J. Mol. Sci. 2012, 13                      
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transport  [36].  Lidocaine  (10  mM)  decreases  the  number  and  the  velocity  of  the  CM-DiI-labeled 
vesicles. The lower concentrations of lidocaine (0.1 and 1 mM) produced no effect (data not shown). 
Interestingly, lidocaine preferentially suppressed the antero- and retrograde moving particles with a 
velocity of less than 2.16 μm/s.  
Many  anti-cancer  drugs  have  neuropathic  side  effects.  For  example,  paclitaxel  stimulates  and 
vincristine  inhibits  the  polymerization  of  β-tubulin  to  α-tubulin,  resulting  in  the  appearance  of 
microtubule bundles and some aberrant structures in the mitotic phase of the cell cycle [37]. A possible 
disturbance of microtubule functions may affect axonal transport and other cellular functions of sensory 
neurons. However, the mechanisms for untoward effects, including neuropathic side effects, are largely 
unknown.  If  neuropathic  side  effects  are  associated  with  the  disturbances  of  axonal  transport,  
anti-neoplastic agents without neuropathic side effects may have no effect on axonal transport. Using our 
system, we investigated the effects on axonal transport of several anti-cancer drugs having different sites 
of action. We treated DRG neurons with paclitaxel, vincristine, cisplatin, oxaliplatin, methotrexate and  
5-fluorouracil.  Cisplatin  and  oxaliplatin  react  with  DNA,  forming  both  intrastrand  and  interstrand  
cross-links. Cisplatin also inhibits the polymerization of microtubules. Methotrexate (an inhibitor of 
enzyme dihydrofolate reductase) and 5-fluorouracil (an inhibitor of tymidine monophosphate) inhibit 
DNA synthesis. As expected, we found that paclitaxel, vincristine, cisplatin and oxaliplatin, all disrupt 
both antero- and retrograde axonal transport and decrease the number of CM-DiI-labeled vesicles. 
Furthermore, this system also allows us to confirm concentration-dependent inhibition by paclitaxel  
(1, 10 and 100 nM), vincristine (10, 50 and 100 pM) and cisplatin (0.1, 1 and 10 μM) of antero- and 
retrograde axonal transport. The IC50 values for antero- or retrograde axonal transport of paclitaxel, 
vincristine and cisplatin were 4.1 or 5.5 nM, 100 or 130 pM, and 3.0 or 5.5 μM, respectively. These 
values are comparable to the effective concentrations that inhibit the growth of tumor cells [38–40], 
further indicating the validity of this assay system for axonal transport. These findings together suggest 
that neuropathic side effects are associated with the disturbances of axonal transport. 
Using  this  system,  we  have  discovered  that  the  effects  of  these  pharmacological  agents  have 
differential effects on each component of axonal transport. Oxaliplatin shows a tendency to inhibit the 
fast component of antero- and retrograde axonal transport with a velocity faster than 2 μm/s (Figure 5). 
On the other hand, paclitaxel inhibits moving vesicles with a velocity slower than 3 μm/s. We also 
found that 5-fluorouracil and methotrexate do not produce significant effects on axonal transport, but 
increase the fast and the slow components of antero- and retrograde axonal transport, respectively 
(Figure 5). In this case, neither 5-fluorouracil nor methotrexate suppressed the total number of moving 
particles (data not shown). It is unknown how these agents augment the slow components of axonal 
transport.  It  would  be  interesting  to  note  the  difference  between  5-fluorouracil  and  paclitaxel  or 
vincristine.  Intracellular  cargos  are  transported  by  multiple  motor  proteins,  and  each  motor  has  a 
characteristic velocity. These agents may have distinct sites of action, which may have relevance to 
their differential effects on axonal transport. Int. J. Mol. Sci. 2012, 13                      
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Figure 5. The effects of anti-neoplastic agents, 5-fluorouracil (100 μM) (A), methotrexate 
(100 μM) (B) on the number of moving particles (/2 min) labeled with CM-DiI in axons of 
DRG neurons 24 h after the application of anti-neoplastic agents. Data are means ±  S.E.M. 
(n = 5). * p < 0.05, ** p < 0.01 (Mann-Whitney’s U-test), compared to corresponding 
control. From [Goshima et al. 2010] [4]. 
 
3. Experimental Section 
CM-DiI  was  purchased  from  Invitrogen  (Eugene,  Oregon,  USA).  Poly-L-lysine,  sodium  azide, 
nocodazole, vinblastine sulfate, cisplatin, oxaliplatin, 5-fluorouracil, cytochalasin B and lidocaine were 
from Sigma (St. Louis, MO, USA). Paclitaxel was from Wako (Osaka, Japan). Methotrexate was from 
Fluka (Buchs, Switzerland). DRGs were removed from embryonic day-7 chick embryos, and were 
treated with 0.25% trypsin in Ca
2+- and Mg
2+-free phosphate buffered saline at 37 ° C for 6 min, and 
stopped by adding trypsin-free medium, as described [41]. The cells were washed three times in Ham’s 
F12 medium (Sigma) containing 10% fetal bovine serum and 2.5 S nerve growth factor (10 ng/mL; 
Wako), dissociated in the medium, and seeded onto a 35-mm cell culture dish (CORNING, USA). The 
cells were cultured for 1 h, the medium was collected, and replated onto a Poly-L-lysine-coated 35-mm 
glass base dish (Iwaki, Japan). The cells were then cultured at 37 ° C for 12–14 h. The cultured cells 
were washed three times in Leibovitz’s L-15 medium (L-15 medium) (GIBCO, Eggenstein, Germany), 
and cultured for 30 min in L-15 medium containing CM-DiI (2 mM) and 2.5 S nerve growth factor  
(10 ng/mL; Wako). The cells were washed three times with L-15 medium, then incubated for 6 h in the 
CM-DiI-free culture medium to remove any excess dye loaded in the DRG neurons. The absolute value 
of the number of DiI-labeled moving particles (/2 min) at the start of the experiments varied among the 
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DRG neurons examined. This was probably due to certain differences in the culture conditions and/or 
developmental  stages  of  the  neurons.  To  characterize  the  particles  stained  with  CM-DiI,  double 
staining with CM-DiI and mitoTracker or erTracker was performed in DRG neurons. The procedures 
involving the experimental animal complied with the animal care guidelines of the National Institutes 
of Health and the animal ethics committee of Yokohama City University.  
CM-DiI-labeled moving particles in the axons of cultured DRG neurons were observed using a 
laser-scanning microscope with a water-immersed objective set at × 40 (C-Apochromat/1.2 W corr) 
equipped with an Axioplan 2 imaging microscope (Carl Zeiss). The images were typically 644 ×  130 pixels, 
corresponding to an image size of 75 ×  15.1 μm using a pixel size of 0.12 μm. The images were 
collected every 0.5 μs, at intervals of 0.25 μs, for 2 min. 
Data are expressed as means ± S.E.M. of n experiments. The results were analyzed using Student’s 
t-test and Mann-Whitney U-test.  
4. Conclusions 
In conclusion, we have established a system which allows prompt and accurate analysis of axonal 
transport that can visualize moving particles, and which may be applied together with other probes and 
recent imaging techniques. Future studies may include application of this assay system to analyze 
frequency of movement measured, distance traveled and other complex patterns of movement  per 
cargo particle. This system affords a chemical biology strategy for evaluating neurotoxic effects of 
candidate  therapeutic  agents  and  chemicals  for  side-effect,  hazard  and  risk  assessment,  and  for 
developing novel therapeutic agents to restore affected axonal transport in various kinds of neuronal 
cells  originating  from  central  and  peripheral  nervous  tissue,  or  disease-related  pluripotent  
stem cells [42].  
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